RhumbLine Advisers’s ICU Medical ICUI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.86M | Buy |
68,639
+490
| +0.7% | +$70.4K | 0.01% | 1119 |
|
|
2025
Q4 | $9.72M | Sell |
68,149
-1,042
| -2% | -$140K | 0.01% | 1072 |
|
|
2025
Q3 | $8.3M | Buy |
69,191
+210
| +0.3% | +$26.6K | 0.01% | 1169 |
|
|
2025
Q2 | $9.12M | Buy |
68,981
+4,159
| +6% | +$564K | 0.01% | 1092 |
|
|
2025
Q1 | $9M | Sell |
64,822
-3,069
| -5% | -$476K | 0.01% | 1063 |
|
|
2024
Q4 | $10.5M | Sell |
67,891
-3,287
| -5% | -$556K | 0.01% | 1030 |
|
|
2024
Q3 | $13M | Buy |
71,178
+4,262
| +6% | +$631K | 0.01% | 942 |
|
|
2024
Q2 | $7.95M | Buy |
66,916
+12,519
| +23% | +$1.32M | 0.01% | 1141 |
|
|
2024
Q1 | $5.84M | Sell |
54,397
-7,711
| -12% | -$767K | 0.01% | 1330 |
|
|
2023
Q4 | $6.19M | Sell |
62,108
-154
| -0.2% | -$15.1K | 0.01% | 1285 |
|
|
2023
Q3 | $7.41M | Sell |
62,262
-483
| -0.8% | -$72.1K | 0.01% | 1135 |
|
|
2023
Q2 | $11.2M | Sell |
62,745
-2,270
| -3% | -$416K | 0.01% | 961 |
|
|
2023
Q1 | $10.7M | Sell |
65,015
-433
| -0.7% | -$74.5K | 0.01% | 932 |
|
|
2022
Q4 | $10.3M | Buy |
65,448
+4,507
| +7% | +$686K | 0.01% | 926 |
|
|
2022
Q3 | $9.18M | Buy |
60,941
+1,829
| +3% | +$304K | 0.01% | 929 |
|
|
2022
Q2 | $9.72M | Buy |
59,112
+5,957
| +11% | +$1.15M | 0.01% | 909 |
|
|
2022
Q1 | $11.8M | Sell |
53,155
-1,352
| -2% | -$303K | 0.02% | 868 |
|
|
2021
Q4 | $12.9M | Buy |
54,507
+1,192
| +2% | +$278K | 0.02% | 848 |
|
|
2021
Q3 | $12.4M | Sell |
53,315
-1,451
| -3% | -$304K | 0.02% | 842 |
|
|
2021
Q2 | $11.3M | Sell |
54,766
-739
| -1% | -$152K | 0.01% | 928 |
|
|
2021
Q1 | $11.4M | Sell |
55,505
-548
| -1% | -$116K | 0.02% | 908 |
|
|
2020
Q4 | $12M | Buy |
56,053
+154
| +0.3% | +$29.9K | 0.02% | 816 |
|
|
2020
Q3 | $10.2M | Sell |
55,899
-1,331
| -2% | -$251K | 0.02% | 767 |
|
|
2020
Q2 | $10.5M | Buy |
57,230
+1,616
| +3% | +$321K | 0.02% | 750 |
|
|
2020
Q1 | $11.2M | Buy |
55,614
+2,832
| +5% | +$545K | 0.02% | 616 |
|
|
2019
Q4 | $9.88M | Sell |
52,782
-548
| -1% | -$94.3K | 0.02% | 840 |
|
|
2019
Q3 | $8.51M | Buy |
53,330
+3,771
| +8% | +$751K | 0.02% | 861 |
|
|
2019
Q2 | $12.5M | Buy |
49,559
+3,658
| +8% | +$848K | 0.02% | 669 |
|
|
2019
Q1 | $11M | Buy |
45,901
+575
| +1% | +$138K | 0.02% | 714 |
|
|
2018
Q4 | $10.4M | Buy |
45,326
+12,261
| +37% | +$3.02M | 0.02% | 693 |
|
|
2018
Q3 | $9.35M | Buy |
33,065
+164
| +0.5% | +$48K | 0.02% | 714 |
|
|
2018
Q2 | $9.66M | Buy |
32,901
+1,692
| +5% | +$462K | 0.02% | 698 |
|
|
2018
Q1 | $7.88M | Sell |
31,209
-4,959
| -14% | -$1.17M | 0.02% | 773 |
|
|
2017
Q4 | $7.81M | Buy |
36,168
+5,037
| +16% | +$1.02M | 0.02% | 816 |
|
|
2017
Q3 | $5.79M | Buy |
31,131
+575
| +2% | +$100K | 0.01% | 953 |
|
|
2017
Q2 | $5.27M | Sell |
30,556
-243
| -0.8% | -$39K | 0.01% | 973 |
|
|
2017
Q1 | $4.7M | Buy |
30,799
+8,790
| +40% | +$1.28M | 0.01% | 1042 |
|
|
2016
Q4 | $3.24M | Buy |
22,009
+936
| +4% | +$135K | 0.01% | 1165 |
|
|
2016
Q3 | $2.66M | Buy |
21,073
+1,119
| +6% | +$135K | 0.01% | 1228 |
|
|
2016
Q2 | $2.25M | Sell |
19,954
-1,055
| -5% | -$109K | 0.01% | 1267 |
|
|
2016
Q1 | $2.19M | Buy |
21,009
+1,425
| +7% | +$136K | 0.01% | 1318 |
|
|
2015
Q4 | $2.21M | Buy |
19,584
+892
| +5% | +$98.6K | 0.01% | 1291 |
|
|
2015
Q3 | $2.05M | Buy |
18,692
+977
| +6% | +$105K | 0.01% | 1307 |
|
|
2015
Q2 | $1.7M | Sell |
17,715
-3,200
| -15% | -$299K | 0.01% | 1524 |
|
|
2015
Q1 | $1.95M | Buy |
20,915
+200
| +1% | +$17.5K | 0.01% | 1426 |
|
|
2014
Q4 | $1.7M | Buy |
20,715
+1,025
| +5% | +$78.6K | ﹤0.01% | 1470 |
|
|
2014
Q3 | $1.26M | Sell |
19,690
-720
| -4% | -$44.1K | ﹤0.01% | 1603 |
|
|
2014
Q2 | $1.24M | Buy |
20,410
+4,380
| +27% | +$259K | ﹤0.01% | 1686 |
|
|
2014
Q1 | $960K | Sell |
16,030
-685
| -4% | -$42.2K | ﹤0.01% | 1831 |
|
|
2013
Q4 | $1.06M | Sell |
16,715
-350
| -2% | -$22.5K | ﹤0.01% | 1768 |
|
|
2013
Q3 | $1.16M | Buy |
17,065
+6
| +0% | +$428 | ﹤0.01% | 1686 |
|
|
2013
Q2 | $1.23M | Buy |
+17,059
| New | +$1.13M | ﹤0.01% | 1622 |
|
Other funds holding ICUI
VPM
VCM
RRAM
RhumbLine Advisers's ICUI Position: Q1 2026 in Review
RhumbLine Advisers increased its ICU Medical (ICUI) stake by 0.72% in Q1 2026, buying an estimated $70.4K and bringing the position to 68,639 shares worth $8.86M. The position accounts for 0.01% of the portfolio, ranked #1119.
RhumbLine Advisers first reported a position in ICUI in Q2 2013 and has held it in 52 quarters since. The position peaked at $13M in Q3 2024. 275 funds tracked by Wall St. Rank hold ICUI as of Q1 2026.
- RhumbLine Advisers held 68,639 shares of ICU Medical worth $8.86M as of Q1 2026.
- RhumbLine Advisers bought 490 ICU Medical shares in Q1 2026, an estimated $70.4K.
- ICU Medical made up 0.01% of RhumbLine Advisers's portfolio in Q1 2026, its #1119 holding.
- RhumbLine Advisers first reported a position in ICU Medical in Q2 2013 and has held it in 52 quarters since.
- RhumbLine Advisers's ICU Medical position peaked at $13M in Q3 2024.
- 275 funds tracked by Wall St. Rank held ICU Medical as of Q1 2026.
Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.